176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.94%
Revenue growth 1.25-1.5x AMD's 11.26%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
16.15%
Gross profit growth 1.25-1.5x AMD's 14.35%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
24.95%
Positive EBIT growth while AMD is negative. John Neff might see a substantial edge in operational management.
24.95%
Positive operating income growth while AMD is negative. John Neff might view this as a competitive edge in operations.
24.16%
Positive net income growth while AMD is negative. John Neff might see a big relative performance advantage.
23.38%
Positive EPS growth while AMD is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
23.68%
Positive diluted EPS growth while AMD is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.36%
Share reduction more than 1.5x AMD's 17.95%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.16%
Diluted share reduction more than 1.5x AMD's 15.74%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
0.65%
Dividend growth of 0.65% while AMD is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
43.12%
OCF growth above 1.5x AMD's 4.32%. David Dodd would confirm a clear edge in underlying cash generation.
58.57%
Positive FCF growth while AMD is negative. John Neff would see a strong competitive edge in net cash generation.
517.62%
10Y revenue/share CAGR above 1.5x AMD's 106.92%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
290.42%
5Y revenue/share CAGR 1.25-1.5x AMD's 224.83%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
102.92%
3Y revenue/share CAGR at 50-75% of AMD's 201.49%. Martin Whitman would question if the firm lags behind competitor innovations.
3054.94%
10Y OCF/share CAGR above 1.5x AMD's 472.02%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
1148.88%
5Y OCF/share CAGR 1.25-1.5x AMD's 822.56%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
186.10%
3Y OCF/share CAGR under 50% of AMD's 2338.26%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
1411.18%
Net income/share CAGR above 1.5x AMD's 439.27% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
703.97%
5Y net income/share CAGR similar to AMD's 707.51%. Walter Schloss might see both on parallel mid-term trajectories.
110.00%
Below 50% of AMD's 800.00%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
453.02%
Below 50% of AMD's 2104.67%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
304.44%
Below 50% of AMD's 7451.82%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
134.17%
Below 50% of AMD's 1945.11%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
38.19%
Dividend/share CAGR of 38.19% while AMD is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
7.02%
3Y dividend/share CAGR of 7.02% while AMD is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
18.58%
AR growth well above AMD's 10.11%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.12%
Inventory growth well above AMD's 8.93%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
25.50%
Asset growth above 1.5x AMD's 0.88%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
12.23%
Positive BV/share change while AMD is negative. John Neff sees a clear edge over a competitor losing equity.
63.60%
Debt growth far above AMD's 48.31%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
7.98%
R&D dropping or stable vs. AMD's 22.64%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
1.15%
We expand SG&A while AMD cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.